Downregulation of TRPM1/melastatin mRNA in primary malignant melanoma is a prognostic marker for metastasis [41]; however, the pathobiologic role of TRPM3 in endometrial carcinoma remains largely unknown. This evidence concerns the gene TRPM3 and endometrial carcinoma.